CFB and neoplasm: Since selective targeting of PDGFRβ by 1-NaPP1 strongly affected tumor growth and vasculature leading to a significant decrease in vessel size in both LLC and B16/PDGF-BB tumors, we studied the effect of 1-NaPP1 treatment on tumor vasculature perfusion.